This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Immunomedics Inc (IMMU)

NASDAQ: Health Care

Company Income Statement
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Sales 4.96M 32.73M 14.71M 60.93M
Cost of Sales 392.72K 427.04K 419.35K 45.68M
Gross Operating Profit 4.57M 32.31M 14.29M 15.25M
Selling, General, and Administrative Expenses 6.98M 6.61M 7.94M 6.18M
Research & Development 29.17M 24.82M 25.37M 19.85M
Operating Income before D & A (EBITDA) -31.58M 874.17K -19.02M -10.78M
Depreciation & Amortization 859.37K 1.50M 1.36M -44.72M
Interest Income 10.56K 18.76K 519.01K 788.86K
Other Income - Net 19.34M 13.23K 3.37M 1.05M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -13.09M -590.62K -16.49M 35.77M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -13.09M -590.62K -16.49M 35.77M
Income Taxes 44.07K 209.78K 109.88K -1.23M
Minority Interest -104.76K -113.57K -173.99K 0.00
Net Income From Continuing Operations -12.27M 696.38K -15.24M 37.00M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -12.27M 696.38K -15.24M 37.00M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -12.17M 809.95K -15.07M 37.00M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-12.27M 696.38K -15.24M 37.00M
Preferred Dividends
Net Income Available To Common -12.27M 696.38K -15.24M 37.00M
Basic EPS from Continuing Ops. -0.16 0.01 -0.20 0.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.16 0.01 -0.20 0.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.16 0.01 -0.20 0.49
Basic Normalized Net Income/Share -0.16 0.01 -0.20 0.49
EPS fr Continuing Ops. -0.16 0.01 -0.20 0.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.16 0.01 -0.20 0.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.16 0.01 -0.20 0.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.16 0.01 -0.20 0.49
Dividends Paid per Share 0.00 0.00 0.00 0.00
IMMU News

IMMU Immunomedics Inc

Analysts Ratings for IMMU

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 2 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IMMU ANALYST REPORT

Brokerage Partners

IMMU Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs